Annual EBIT:
$206.60M+$488.04M(+173.41%)Summary
- As of today, CVAC annual earnings before interest & taxes is $206.60 million, with the most recent change of +$488.04 million (+173.41%) on December 31, 2024.
- During the last 3 years, CVAC annual EBIT has risen by +$682.43 million (+143.42%).
- CVAC annual EBIT is now at all-time high.
Performance
CVAC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$57.83M-$4.44M(-8.33%)Summary
- As of today, CVAC quarterly earnings before interest & taxes is -$57.83 million, with the most recent change of -$4.44 million (-8.33%) on March 31, 2025.
- Over the past year, CVAC quarterly EBIT has increased by +$25.98 million (+31.00%).
- CVAC quarterly EBIT is now -113.04% below its all-time high of $443.54 million, reached on September 30, 2024.
Performance
CVAC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$252.33M+$25.98M(+11.48%)Summary
- As of today, CVAC TTM earnings before interest & taxes is $252.33 million, with the most recent change of +$25.98 million (+11.48%) on March 31, 2025.
- Over the past year, CVAC TTM EBIT has increased by +$574.49 million (+178.32%).
- CVAC TTM EBIT is now at all-time high.
Performance
CVAC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CVAC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +173.4% | +31.0% | +178.3% |
| 3Y3 Years | +143.4% | -6.3% | +122.5% |
| 5Y5 Years | +287.0% | -109.3% | +396.0% |
CVAC EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +143.4% | -113.0% | +53.9% | at high | +130.2% |
| 5Y | 5-Year | at high | +143.4% | -113.0% | +91.3% | at high | +120.5% |
| All-Time | All-Time | at high | +143.4% | -113.0% | +91.3% | at high | +120.5% |
CVAC EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$57.83M(-8.3%) | $252.33M(+11.5%) |
| Dec 2024 | $206.60M(+173.4%) | -$53.38M(-112.0%) | $226.35M(+25.8%) |
| Sep 2024 | - | $443.54M(+654.4%) | $179.96M(+155.7%) |
| Jun 2024 | - | -$80.00M(+4.5%) | -$322.94M(-0.2%) |
| Mar 2024 | - | -$83.81M(+16.0%) | -$322.16M(-5.7%) |
| Dec 2023 | -$281.44M(-8.1%) | -$99.78M(-68.1%) | -$304.74M(+7.8%) |
| Sep 2023 | - | -$59.35M(+25.1%) | -$330.50M(-1.9%) |
| Jun 2023 | - | -$79.23M(-19.4%) | -$324.23M(-4.3%) |
| Mar 2023 | - | -$66.38M(+47.1%) | -$310.81M(-4.0%) |
| Dec 2022 | -$260.33M(+45.3%) | -$125.55M(-136.5%) | -$298.82M(+64.3%) |
| Sep 2022 | - | -$53.08M(+19.3%) | -$836.33M(+14.4%) |
| Jun 2022 | - | -$65.80M(-21.0%) | -$977.13M(+13.1%) |
| Mar 2022 | - | -$54.39M(+91.8%) | -$1.12B(+8.6%) |
| Dec 2021 | -$475.83M | -$663.06M(-242.0%) | -$1.23B(-93.2%) |
| Sep 2021 | - | -$193.88M(+8.7%) | -$636.08M(-29.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$212.46M(-33.2%) | -$489.66M(-70.4%) |
| Mar 2021 | - | -$159.54M(-127.3%) | -$287.36M(-84.9%) |
| Dec 2020 | -$123.05M(-11.4%) | -$70.20M(-47.9%) | -$155.45M(-82.3%) |
| Sep 2020 | - | -$47.46M(-367.1%) | -$85.25M(-125.6%) |
| Jun 2020 | - | -$10.16M(+63.2%) | -$37.79M(-36.8%) |
| Mar 2020 | - | -$27.63M(>-9900.0%) | -$27.63M(-8.9%) |
| Dec 2019 | -$110.46M(-32.0%) | $0.00(0.0%) | -$25.38M(0.0%) |
| Sep 2019 | - | $0.00(0.0%) | -$25.38M(0.0%) |
| Jun 2019 | - | $0.00(+100.0%) | -$25.38M(0.0%) |
| Mar 2019 | - | -$25.38M(>-9900.0%) | -$25.38M(>-9900.0%) |
| Dec 2018 | -$83.67M | - | - |
| Dec 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
FAQ
- What is CureVac N.V. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for CureVac N.V.?
- What is CureVac N.V. annual EBIT year-on-year change?
- What is CureVac N.V. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for CureVac N.V.?
- What is CureVac N.V. quarterly EBIT year-on-year change?
- What is CureVac N.V. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for CureVac N.V.?
- What is CureVac N.V. TTM EBIT year-on-year change?
What is CureVac N.V. annual earnings before interest & taxes?
The current annual EBIT of CVAC is $206.60M
What is the all-time high annual EBIT for CureVac N.V.?
CureVac N.V. all-time high annual earnings before interest & taxes is $206.60M
What is CureVac N.V. annual EBIT year-on-year change?
Over the past year, CVAC annual earnings before interest & taxes has changed by +$488.04M (+173.41%)
What is CureVac N.V. quarterly earnings before interest & taxes?
The current quarterly EBIT of CVAC is -$57.83M
What is the all-time high quarterly EBIT for CureVac N.V.?
CureVac N.V. all-time high quarterly earnings before interest & taxes is $443.54M
What is CureVac N.V. quarterly EBIT year-on-year change?
Over the past year, CVAC quarterly earnings before interest & taxes has changed by +$25.98M (+31.00%)
What is CureVac N.V. TTM earnings before interest & taxes?
The current TTM EBIT of CVAC is $252.33M
What is the all-time high TTM EBIT for CureVac N.V.?
CureVac N.V. all-time high TTM earnings before interest & taxes is $252.33M
What is CureVac N.V. TTM EBIT year-on-year change?
Over the past year, CVAC TTM earnings before interest & taxes has changed by +$574.49M (+178.32%)